Medicare prescription drug coverage: A very long wait for a very modest benefit

American Journal of Medicine

Volumn 118, Issue 4, 2005, Pages 325-329

  Dalen, James E ^a   Hartz, Douglas J ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALENDRONIC ACID; AMLODIPINE BESYLATE; ANTICOAGULANT AGENT; ATORVASTATIN; CELECOXIB; CLOPIDOGREL; CONJUGATED ESTROGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; HYDROCHLOROTHIAZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LATANOPROST; METOPROLOL SUCCINATE; NONSTEROID ANTIINFLAMMATORY AGENT;

AGING; ARTHRITIS; CARDIOVASCULAR DISEASE; CONGESTIVE HEART FAILURE; DEPRESSION; DRUG COST; DRUG INDUSTRY; DRUG USE; EDITORIAL; HEALTH ECONOMICS; HEALTH INSURANCE; HUMAN; HYPERLIPIDEMIA; LAW; MEDICARE; OSTEOPOROSIS; PEPTIC ULCER; PRESCRIPTION; PRIORITY JOURNAL; UNITED STATES;

EID: 16244422013     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2004.11.022     Document Type: Article

References (34)

1. T.R. Oliver, P.R. Lee, and H.L. Lipton A political history of Medicare and prescription drug coverage Milbank Q 82 2004 283 354
2. D.E. Altman The new Medicare prescription-drug legislation N Engl J Med 350 2004 9 10
3. J.K. Iglehart Medicare and drug pricing N Engl J Med 348 2003 1590 1597
4. S.B. Soumerai, and D. Ross-Degnan Inadequate prescription-drug coverage for Medicare enrollees-a call to action N Engl J Med 340 1999 722 728
5. U. Sambamoorth, D. Shea, and S. Crystal Total and out-of-pocket expenditures for prescription drugs among older persons Gerontologist 43 2003 345 359
6. G.F. Anderson, D.G. Shea, and P.S. Hussey Doughnut holes and price controls Health Aff (Millwood) 2004 396 404 Jul 21(Web exclusive)
7. E.P. Steinberg, B. Gutierrez, and A. Momani Beyond survey data a claims-based analysis of drug use and spending by the elderly Health Aff (Millwood) 19 2000 198 211
8. J. Henry Kaiser Family Foundation Medicare drug discount cards a work in progress (Executive Summary) 2004 July
9. F.M. Scherer The pharmaceutical industry-prices and progress N Engl J Med 351 2004 927 932
10. C.P. Thomas, G. Ritter, and S.S. Wallack Growth in prescription drug spending among insured elders Health Aff (Millwood) 20 2001 265 277
11. A.V. Chobanian, G.L. Bakris, and H.R. Black and the National High Blood Pressure Education Program Coordinating Committee. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure JAMA 289 2003 2560 2571
12. S.M. Grundy, J.I. Cleeman, and C.N. Merz Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines Circulation 110 2004 227 239
13. C.W. Tseng, R.H. Brook, and E. Keeler Cost-lowering strategies used by Medicare beneficiaries who exceed drug benefit caps and have a gap in drug coverage JAMA 292 2004 952 960
14. C. Patrono, B. Coller, and J.E. Dalen Platelet-active drugs the relationship among dose, effectiveness, and side effects Chest 119 2001 39S 63S
15. S.B. Olsson Executive Steering Committee on behalf of the SPORTIF III Investigators Stroke prevention with oral direct thrombin inhibitor Ximelagatran compared with Warfarin in patients with non-valvular atrial fibrillation (SPORTIF III) randomized controlled trial Lancet 362 2003 1691 1698
16. A. Nohria, E. Lewis, and L.W. Stevenson Medical management of advanced heart failure JAMA 287 2002 628 640
17. R.S. Stafford, R.L. Drieling, and A.L. Hersh National trends in osteoporosis visits and osteoporosis treatment, 1988-2003 Arch Intern Med 164 2004 1525 1530
18. F.E. Silverstein, G. Faich, and J.L. Goldstein Gastrointestinal toxicity with Celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis. The CLASS Study: a randomized controlled trial JAMA 284 2000 1247 1255
19. J. Henry Kaiser Family Foundation Medicare and prescription drugs (Fact Sheet) 2003 April
20. J.F. Moeller, G.E. Miller, and J.S. Banthin Looking inside the nation's medicine cabinet: trends in outpatient drug spending by Medicare beneficiaries, 1997 and 2001: costly new drugs do have an impact on overall drug spending Health Aff (Millwood) 23 2004 217 225
21. Families USA Sticker shock rising prescription drug prices for seniors Families USA 2004 1 20 June; Publication No. 04-103
22. AARP Public Policy Institute Trends in manufacturer prices of brand name prescription drugs used by older Americans (Update) First Quarter 2004 1 12 Jun
23. J.K. Iglehart The new Medicare prescription-drug benefit- a pure power play N Engl J Med 350 2004 826 833
24. P.D. Fox Prescription drug benefits cost management issues for Medicare Health Care Financ Rev 25 2003 7 21
25. J. Henry Kaiser Family Foundation Trends in Medicare supplemental insurance and prescription drug benefits, 1996-2001 (Data Update) 2004 June
26. G.R. Wilensky What's wrong with medicare? N Engl J Med 345 2001 459 461
27. E.D. Moxey, J.P. O'Connor, and K.D. Novielli Prescription drug use in the elderly a descriptive analysis Health Care Financ Rev 24 2003 127 141
28. J. Henry Kaiser Family Foundation Eighteen percent of California seniors and twenty six percent of those in poor health report skipping prescription doses or foregoing medications due to cost, new survey finds (News Release) 2002 Oct
29. D.P. Goldman, G.F. Joyce, and J.J. Escarce Pharmacy benefits and the use of drugs by the chronically ill JAMA 291 2004 2344 2350
30. J.J. Ellis, S.R. Erickson, and J.G. Stevenson Suboptimal statin adherence and discontinuation in primary and secondary prevention populations J Gen Intern Med 19 2004 638 645
31. T.S. Rector, and P.J. Venus Do drug benefits help Medicare beneficiaries afford prescribed drugs? Health Aff (Millwood) 23 2004 213 222
32. J.D. Piette, M. Heisler, and T.H. Wagner Cost-related medication underuse. Do patients with chronic illnesses tell their doctors? Arch Intern Med 164 2004 1749 1755
33. R. Tamblyn, R. Laprise, and J.A. Hanley Adverse events associated with prescription drug cost-sharing among poor and elderly persons JAMA 285 2001 421 429
34. J. Christian-Herman, M. Emons, and D. George Effects of generic-only drug coverage in a medicare HMO Health Aff (Millwood) 2004 455 468 (Web exclusive)